glp 1 drugs and diverticulitis What is the risk of diverticular disease (diverticulosis or diverticulitis) associated with GLP‑1 receptor agonist therapy in adults with type 2 diabetes? Ozempic and Diverticulitis: Risks and
Description
Exenatide has a relatively short half-life, (6090 min in humans, Kolterman et al., 2005) and is recommended for twice-daily administration
Clinical trial data demonstrates that Wegovy pill produces significant, sustained weight loss when combined with lifestyle modifications like a reduced-calorie diet and increased physical activity
Onglyza (saxagliptin): US prescribing information
Available from: ScienceDirect Frontiers review: Du H, et al
They are also among the most preventable with the right preparation
[DOI] [PubMed] [Google Scholar] Obach R
